Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 155

Related Citations for PubMed (Select 1346877)

1.

Respiratory disease in very-low-birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoid. TRH Study Group.

Ballard RA, Ballard PL, Creasy RK, Padbury J, Polk DH, Bracken M, Moya FR, Gross I.

Lancet. 1992 Feb 29;339(8792):510-5.

PMID:
1346877
2.

Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants. North American Thyrotropin-Releasing Hormone Study Group.

Ballard RA, Ballard PL, Cnaan A, Pinto-Martin J, Davis DJ, Padbury JF, Phibbs RH, Parer JT, Hart MC, Mannino FL, Sawai SK.

N Engl J Med. 1998 Feb 19;338(8):493-8.

3.
4.
5.
6.

Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial.

Crowther CA, Haslam RR, Hiller JE, Doyle LW, Robinson JS; Australasian Collaborative Trial of Repeat Doses of Steroids (ACTORDS) Study Group.

Lancet. 2006 Jun 10;367(9526):1913-9.

PMID:
16765760
7.

Early postnatal dexamethasone therapy for the prevention of chronic lung disease.

Vermont Oxford Network Steroid Study Group.

Pediatrics. 2001 Sep;108(3):741-8.

PMID:
11533345
8.

The effect of corticosteroid therapy in the very premature infant. March of Dimes Multicenter Study Group.

Maher JE, Cliver SP, Goldenberg RL, Davis RO, Copper RL.

Am J Obstet Gynecol. 1994 Mar;170(3):869-73.

PMID:
8141218
11.

Two trials of antenatal thyrotrophin-releasing hormone for fetal maturation: stopping before the due date. Antenatal TRH Trial and the Thyroneth Trial Groups.

Alfirevic Z, Boer K, Borcklehurst P, Buimer M, Elbourne D, Kok J, Tansey S.

Br J Obstet Gynaecol. 1999 Sep;106(9):898-906.

PMID:
10492099
12.
13.

Is there a role for antenatal TRH therapy for the prevention of neonatal lung disease?

Gross I, Moya FR.

Semin Perinatol. 2001 Dec;25(6):406-16. Review.

PMID:
11778911
14.

Thyrotropin-releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease.

Crowther CA, Alfirevic Z, Han S, Haslam RR.

Cochrane Database Syst Rev. 2013 Nov 21;11:CD000019. doi: 10.1002/14651858.CD000019.pub3. Review.

PMID:
24265169
15.

Plasma thyroid hormones and prolactin in premature infants and their mothers after prenatal treatment with thyrotropin-releasing hormone.

Ballard PL, Ballard RA, Creasy RK, Padbury J, Polk DH, Bracken M, Moya FR, Gross I.

Pediatr Res. 1992 Dec;32(6):673-8.

PMID:
1287557
16.

A randomized, placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 weeks' gestation.

Garite TJ, Rumney PJ, Briggs GG, Harding JA, Nageotte MP, Towers CV, Freeman RK.

Am J Obstet Gynecol. 1992 Feb;166(2):646-51.

PMID:
1536246
17.

Inhaled nitric oxide in premature infants with the respiratory distress syndrome.

Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P.

N Engl J Med. 2003 Nov 27;349(22):2099-107.

18.

Chronic lung disease of prematurity and intrauterine growth retardation: a population-based study.

Lal MK, Manktelow BN, Draper ES, Field DJ; Population-based study.

Pediatrics. 2003 Mar;111(3):483-7.

PMID:
12612225
19.

Randomized trial of a single repeat dose of prenatal betamethasone treatment in imminent preterm birth.

Peltoniemi OM, Kari MA, Tammela O, Lehtonen L, Marttila R, Halmesmäki E, Jouppila P, Hallman M; Repeat Antenatal Betamethasone Study Group.

Pediatrics. 2007 Feb;119(2):290-8.

20.

Impact of antenatal dexamethasone administration on respiratory distress syndrome in surfactant-treated infants.

Farrell EE, Silver RK, Kimberlin LV, Wolf ES, Dusik JM.

Am J Obstet Gynecol. 1989 Sep;161(3):628-33.

PMID:
2675599
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk